Menu
Back to User profile » Dr Kiyoshi Fujita
Papers published by Dr Kiyoshi Fujita:
Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report
Kitaguchi N, Kato T, Matsunaga S, Hirano K, Iwata K, Kawaguchi K, Fujita K, Takechi H, Hasegawa M, Yuzawa Y, Ito K
Neuropsychiatric Disease and Treatment 2018, 14:2931-2937
Published Date: 1 November 2018
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Neuropsychiatric Disease and Treatment 2018, 14:2519-2530
Published Date: 1 October 2018
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2017, 13:117-125
Published Date: 6 January 2017
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2016, 12:3041-3049
Published Date: 28 November 2016
Early prediction of blonanserin response in Japanese patients with schizophrenia
Kishi T, Matsuda Y, Fujita K, Iwata N
Neuropsychiatric Disease and Treatment 2014, 10:1861-1866
Published Date: 23 September 2014
Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder
Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, Iwata N
Neuropsychiatric Disease and Treatment 2013, 9:781-786
Published Date: 5 June 2013